搜索优化
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
时间不限
过去 1 小时
过去 24 小时
过去 7 天
过去 30 天
按时间排序
按相关度排序
30 分钟
Weighty issue: Obesity can cause over 200 medical problems such as heart failure, cancer
For some individuals, obesity may play a secondary role in their medical problems by exacerbating existing conditions. For ...
HealthDay on MSN
20 小时
Weight Loss Drugs Like Ozempic, Wegovy May Help Fight Alcoholism and Opioid Addiction
A new study reveals that glucagon-like peptide-1 receptor agonists (GLP-1), which include weight loss and diabetes meds ...
1 天
Scientists Discover Amazing New Benefit of Ozempic: Reducing Alcohol and Opioid Addiction
New research shows that Ozempic and similar drugs reduce opioid overdoses by 40% and alcohol intoxication by 50% in people ...
Managed Healthcare Executive
1 天
In the Real World, People Do Not Stick With GLP-1s for Weight Loss | AMCP Nexus 2024
Only 15% of those who start a glucagon-like peptide 1 (GLP-1) for weight loss are still taking it two years according to ...
1 天
Consumer groups ask FTC to block Novo Holdings-Catalent deal
U.S. consumer groups and two large labor unions urged the U.S. Federal Trade Commission on Thursday to block Novo Holdings, ...
1 天
on MSN
Bariatric surgery found to be more cost effective than newer weight loss drugs alone
Newer weight loss drugs are cost effective in the long term only when combined with bariatric weight loss surgery, according ...
Medscape
1 天
Can Weight Loss Drugs Also Treat Addiction?
GLP-1 receptor agonists and similar drugs may protect people with opioid or alcohol use disorder from opioid overdose and ...
1 天
Weight-loss drugs may reduce opioid and alcohol abuse by up to 50%, study finds
Weight-loss drugs such as Ozempic, made by Denmark's Novo Nordisk, can reduce rates of opioid and alcohol abuse by up to 50%, according to a new study that supports expectations the drugs can offer ...
Opinion
1 天
Opinion
New weight loss drugs raise questions of access, costs
New, popular injectable weight loss drugs — GLP-1 drugs — are highly effective at reducing obesity and, probably, the health ...
STAT
1 天
Consumer and labor groups urge FTC to block Catalent sale to Novo Holdings
The coalition said in a letter sent to the FTC Thursday that the deal could reduce access to GLP-1s, and harm competition in ...
Healthline
1 天
Ozempic Microdosing Is Gaining Popularity. Does It Work for Weight Loss?
What health experts think of the growing Ozempic “microdosing” trend that claims taking very small doses of GLP-1 drugs can ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈